Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
(2018) In Nature Medicine 24. p.463-473- Abstract
Breast tumors of the basal-like, hormone receptor-negative subtype remain an unmet clinical challenge, as there is high rate of recurrence and poor survival in patients following treatment. Coevolution of the malignant mammary epithelium and its underlying stroma instigates cancer-associated fibroblasts (CAFs) to support most, if not all, hallmarks of cancer progression. Here we delineate a previously unappreciated role for CAFs as determinants of the molecular subtype of breast cancer. We identified paracrine crosstalk between cancer cells expressing platelet-derived growth factor (PDGF)-CC and CAFs expressing the cognate receptors in human basal-like mammary carcinomas. Genetic or pharmacological intervention of PDGF-CC activity in... (More)
Breast tumors of the basal-like, hormone receptor-negative subtype remain an unmet clinical challenge, as there is high rate of recurrence and poor survival in patients following treatment. Coevolution of the malignant mammary epithelium and its underlying stroma instigates cancer-associated fibroblasts (CAFs) to support most, if not all, hallmarks of cancer progression. Here we delineate a previously unappreciated role for CAFs as determinants of the molecular subtype of breast cancer. We identified paracrine crosstalk between cancer cells expressing platelet-derived growth factor (PDGF)-CC and CAFs expressing the cognate receptors in human basal-like mammary carcinomas. Genetic or pharmacological intervention of PDGF-CC activity in mouse models of cancer resulted in conversion of basal-like breast cancers into a hormone receptor-positive state that enhanced sensitivity to endocrine therapy in previously resistant tumors. We conclude that specification of breast cancer to the basal-like subtype is under microenvironmental control and is therapeutically actionable.
(Less)
- author
- organization
-
- Division of Translational Cancer Research
- Experimental oncology (research group)
- Breastcancer-genetics
- The Liquid Biopsy and Tumor Progression in Breast Cancer (research group)
- Tumor Cell Biology (research group)
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Translational Oncogenomics (research group)
- Division of Clinical Genetics
- publishing date
- 2018-03-12
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Medicine
- volume
- 24
- pages
- 463 - 473
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:29529015
- scopus:85045313361
- ISSN
- 1546-170X
- DOI
- 10.1038/nm.4494
- language
- English
- LU publication?
- yes
- id
- db722ef0-ee34-4c0a-920b-a56604989987
- date added to LUP
- 2018-03-21 14:31:37
- date last changed
- 2023-11-17 16:12:32
@article{db722ef0-ee34-4c0a-920b-a56604989987, abstract = {{<p>Breast tumors of the basal-like, hormone receptor-negative subtype remain an unmet clinical challenge, as there is high rate of recurrence and poor survival in patients following treatment. Coevolution of the malignant mammary epithelium and its underlying stroma instigates cancer-associated fibroblasts (CAFs) to support most, if not all, hallmarks of cancer progression. Here we delineate a previously unappreciated role for CAFs as determinants of the molecular subtype of breast cancer. We identified paracrine crosstalk between cancer cells expressing platelet-derived growth factor (PDGF)-CC and CAFs expressing the cognate receptors in human basal-like mammary carcinomas. Genetic or pharmacological intervention of PDGF-CC activity in mouse models of cancer resulted in conversion of basal-like breast cancers into a hormone receptor-positive state that enhanced sensitivity to endocrine therapy in previously resistant tumors. We conclude that specification of breast cancer to the basal-like subtype is under microenvironmental control and is therapeutically actionable.</p>}}, author = {{Roswall, Pernilla and Bocci, Matteo and Bartoschek, Michael and Li, Hong and Kristiansen, Glen and Jansson, Sara and Lehn, Sophie and Sjölund, Jonas and Reid, Steven and Larsson, Christer and Eriksson, Pontus and Anderberg, Charlotte and Cortez, Eliane and Saal, Lao H and Orsmark-Pietras, Christina and Cordero, Eugenia and Haller, Bengt Kristian and Häkkinen, Jari and Burvenich, Ingrid J G and Lim, Elgene and Orimo, Akira and Höglund, Mattias and Rydén, Lisa and Moch, Holger and Scott, Andrew M and Eriksson, Ulf and Pietras, Kristian}}, issn = {{1546-170X}}, language = {{eng}}, month = {{03}}, pages = {{463--473}}, publisher = {{Nature Publishing Group}}, series = {{Nature Medicine}}, title = {{Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling}}, url = {{http://dx.doi.org/10.1038/nm.4494}}, doi = {{10.1038/nm.4494}}, volume = {{24}}, year = {{2018}}, }